Article

Adjuvant treatment, tumour recurrence and the survival rate of uterine serous carcinomas: a single-institution review of 62 women

Published in: Southern African Journal of Gynaecological Oncology
Volume 7 , issue 1 , 2015 , pages: 14–20

DOI: 10.1080/20742835.2015.1030891

Author(s): F Pol Department of Obstetrics and Gynaecology, the Netherlands , D Allen Department of Gynaelogical Oncology, Australia , R Bekkers Department of Obstetrics and Gynaecology, the Netherlands , P Grant Department of Gynaelogical Oncology, Australia , S Hyde Department of Gynaelogical Oncology, Australia

Keywords: USC , endometrial cancer , adjuvant treatment , recurrence rates , survival rates

Download full text Get new issue alerts

Abstract

Objectives: The aim of this study was to assess our department’s management of uterine serous carcinoma (USC) and to determine the correlation of the recurrence and survival rates of stage I-IV patients with different adjuvant treatment modalities.

« Living with the late effects of cervical cancer treatment: a descriptive qualitative study at an academic hospital in Gauteng

Epithelioid trophoblastic tumour: a report of two cases »